Filing Details
- Accession Number:
- 0000899866-13-000116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-15 17:23:53
- Reporting Period:
- 2013-05-14
- Filing Date:
- 2013-05-15
- Accepted Time:
- 2013-05-15 17:23:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231949 | Leonard Bell | C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2013-05-14 | 22,214 | $105.38 | 1,370,111 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2013-05-14 | 6,566 | $106.32 | 1,363,545 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2013-05-14 | 2,333 | $107.48 | 1,361,212 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $104.90 - $105.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $105.93 - $106.93. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $107.03 - $108.03. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
